期刊文献+

江西省2004~2007年流行性脑脊髓膜炎流行病学特征分析 被引量:2

Epidemiological Characteristic Analysis of the Meningococcal Meningitis in Jiangxi Province During 2004~2007
原文传递
导出
摘要 目的分析江西省流行性脑脊髓膜炎(流脑)流行病学特征,为预防和控制流脑提供依据。方法用描述流行病学方法,对江西省疾病监测信息管理系统报告的2004~2007年流脑流行趋势进行分析。结果江西省2004~2007年流脑发病率为0.069/10万~0.129/10万,平均发病率0.105/10万;病死率为2.2%~16.7%;1~4月为发病高峰;<15岁儿童发病占总病例数的75.4%;学生发病占总病例数的57.5%;送检的病例标本中,检出C群脑膜炎球菌的占73.9%。结论应规范接种A群、A+C群脑膜炎球菌疫苗,加强流脑监测和在校学生流脑的预防控制。 Objective To analyze the epidemiological characteristics of meningococcal meningitis in Jiangxi province, and provide basis for the disease control and preveution. Methods Adopted description epidemiological method to analyze epidemic situation of meningococcal meningitis. Data collected from Jiangxi disease surveillance information system. Results The incidence of meningococcal meningitis was 0.069 -0.129/100 000, average incidente was 0.105/100 000 and the death rate was 2.2%-16.7%. The seasons peak of incidence meningococcal meningitis was 1-4 month.The cases of children who younger than 15 years old accounted for 75.4% of the total cases. The cases of students was 57.5% of total cases. C group of meningococcal meningitis was 73.9% of total inspected meningococcal meningitis. Conclusions Meningococcal meningitis vaccination should be integrated into Expanded Program on Immunization. Practice of immunigation should be standarded. The Surveillance,control and prevention of meningococcal meningitis disease in schools should be strengthened.
出处 《中国疫苗和免疫》 CAS 2009年第3期236-237,共2页 Chinese Journal of Vaccines and Immunization
关键词 流行性脑脊髓膜炎 流行病学特征 Meningococcal meningitis Epidemiological characteristic
  • 相关文献

参考文献4

二级参考文献12

  • 1胡绪敬.流脑流行的监测与预防[J].中国公共卫生,2004,20(5):638-640. 被引量:115
  • 2吕治林.脑膜炎球菌病的流行病学与预防[J].国外医学(流行病学.传染病学分册),1996,23(3):133-136. 被引量:4
  • 3施国庆.流行性脑脊髓膜炎[M].合肥:安徽科学技术出版社,2001.173-181.
  • 4CDC.Preventuon and Control of Meningococcal Disease[J].MMWR,2005,54(RR-7):11-4.
  • 5WHO.关于脑膜炎球菌疫苗的意见书.WER,2002,77(40):331-339.
  • 6Gold R,Lepow M L,Gold scheneider I,et al.Antibody response of human infants to three doses of group A Neisseria meningitidis polysaccharide vaccine administered at two,four and six months of age[J].J Infect Dis,1978,138(6):731-735.
  • 7Granoff D M,Gupta R K,Belshe R B,et al.Induction of immunological refractoriness in adults by meningococcal C polysaccharide vaccination[J].J Infect Dis,1998,178(3):870-874.
  • 8Armand J,Arminjon,F,Mynard M C,et al.Tetravalent meningococcal polysaccharide vaccine group A,C,Y,W135:Clinical and serological evaluation[J].J Biol Stand,1982,10(4):335-339.
  • 9Vodopija L,Baklaic Z,Hauser P,et al.Reactivity and immunogenicity of bivalent (A+C)and tetravalent(ACW135 Y)meningococcal vaccines containing O-acetyl-negative or O-acetyl-positive group C polysaccharide[J].Infect Immun,1983,42(2):599-604.
  • 10胡绪敬.流行性脑脊髓膜炎的流行病学监测与预防[J].中国计划免疫,2001,7(5):300-303. 被引量:135

共引文献169

同被引文献27

  • 1马瑞,宋国华,李岩.1996~2004年哈尔滨市流行性脑脊髓膜炎流行病学分析[J].中国公共卫生管理,2006,22(1):52-53. 被引量:6
  • 2池云,魏红霞,姚文虎.10例C群流行性脑脊髓膜炎分析[J].东南大学学报(医学版),2006,25(4):298-299. 被引量:2
  • 3张银豪,王冬,黎唏,彭春珍,刘明智,杨涛.宁夏1958-2005年流行性脑脊髓膜炎疫情分析[J].宁夏医学杂志,2006,28(9):680-682. 被引量:7
  • 4张宏,杭惠,须勤燕.苏州市流脑流行病学分析[J].现代预防医学,2006,33(10):1864-1866. 被引量:6
  • 5BRANDTZAEG P,VAN DEUREN. Meningoeoceal infections at the start of the 21st century [M]//KAPPY MS, ACCURSO FJ, GILBERT BE ,et al. Advances in Pediatrics. St. Louis, Missouri, USA : Mosby, Inc. ,2005 : 129 - 162.
  • 6GRANOFF DM, HARRISON LH, BORROW R. Meningococcai vaccines[M]//PLOTKIN SA,OFFIT PA, ORENSTEIN WA, et al. Vaccines. Netherlands : Elsevier,2008:679 - 689.
  • 7NI JD, JIN YH, DAI B, et al. Recent epidemiological changes in meningococcal diease may be due to the displacement of serogroup A by serogroup C in Hefei city[ J]. Postgrad Med, 2008, 84(998) :87 -92.
  • 8MILLER E, SALISBURY D, RAMSAY M. Planning, Registration and implementation of an immunisation campaign against meningococcal serogroup C disease in the U K: A success story[J]. Vaccine, 2001,20 (S) : 58 - 67.
  • 9ZOLLINGER WD, MORAN EE, DEVI SJ, et al. Bactericidal antibody responses of juvenile rhesus monkeys immunized with group B Neisseria meningitidis capsular polysaccharide-protein conjugate vaccines [ J ]. Infect Immun, 1997,65 (3) : 1053 - 1060.
  • 10HOLST J, FEIRING B,NAESS LM,et al. The concept of "tailor made", protein based, outer membrane vesicle vaccines against meningococcal disease[J]. Vaccine,2005,23 ( 17 - 18 ) : 2202 - 2205.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部